The Office will be closed on Thursday November 28th and Friday November 29th in observance of theThanksgiving Holiday.
Advanced Pain and Neuromuscular Consultants of Brevard offers a comprehensive approach for the treatment chronic pain.
Chronic pain can rule your life, interfering with your ability to work, sleep and enjoy your family and friends. When chronic pain disrupts your quality of life and does not improve with standard treatments, Advanced Pain and Neuromuscular Consultants of Brevard is here to help.
There are many safe, proven effective treatments available that can eliminate or reduce chronic pain. The sooner you seek treatment, the sooner you can start enjoying life again.
We welcome you to come and learn more about our services. Please contact us if you have any additional questions.
Advanced Pain and Neuromuscular Consultants of Brevard specialists are Board-certified physicians are dedicated to the goal of helping people with chronic pain return to a normal, productive lifestyle.
Many of the patients referred to us have been through multiple other treatment options including interventional pain therapy and surgery.
Our physicians take into account all prior treatment modalities then, utilizing the best of current medical knowledge and technology, we will work with you to identify the source of your pain, then design what they feel will be your most effective pain relief program.
Thank you for visiting us!
Patient Safety Alert 4/5/13
Green Valley Drugs Announces Voluntary Nationwide Recall of All Lots of All Sterile Products
Compounded, Repackaged, and Distributed by Green Valley Drugs Due to Quality Control Concerns
FOR IMMEDIATE RELEASE - April 5, 2013 - Henderson, NV, Green Valley Drugs is voluntarily recalling All Lots of All Sterile products compounded, repackaged, and distributed by the pharmacy due to lack of sterility assurance and concerns associated with the quality control processes. A full list of the recalled products is attached to this press release and can be accessed at greenvalleymed.com. The recall of sterile products is conducted based on observations of clean room personnel and certain aseptic techniques.
Green Valley has received no reports of injury or illness associated with the use of our sterile products. In addition, we have received no indications of endotoxins or sterility issues from independent outside testing laboratories associated with any of the products subject to this recall. Out of an abundance of caution and in the interest of our patients, Green Valley Drugs has decided to voluntarily proceed with this recall process.
In the event a sterile product is compromised patients are at risk for serious and possible life threatening infections.
Green Valley Drugs sterile products covered under this recall were distributed nationwide. Until further notice, health care providers should stop using all lots of sterile products and return them to the company.
Consumers or Health Care providers with questions regarding this recall may contact Green Valley Drugs by phone at 702-564-2079 or e-mail address at firstname.lastname@example.org; Monday through Friday between the hours of 9 am to 5 pm PST. Patients who have received any product distributed by Green Valley Drugs and have concerns should contact their healthcare provider.
Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
****Advanced Pain & Neuromuscular Consultants have NEVER USED PRODUCTS FROM THIS COMPANY.
Patient Safety Alert 4/16/13
Posted By Dan Grams
ISSUE: ApothéCure, Inc. is voluntarily recalling all lots of sterile products compounded by the pharmacy that are not expired to the user level. The recall is being initiated due to the lack of sterility assurance and concerns associated with the quality control processes
BACKGROUND: The sterile products include all injectables with the clear message, "Independently tested for sterility,” noted on the vials as well as the ApothéCure name. ApothéCure’s sterile products covered under this recall were distributed nationwide and supplied to the offices of licensed medical professionals. To date, ApothéCure, Inc. has received no reports of injury or illness associated with the use of our sterile products. However, out of abundance of caution and in the interest of our patients, ApothéCure, Inc. has decided to voluntarily proceed with this recall process.
Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:
Read the MedWatch Safety Alert, including links to the Press Release HERE.
Source: U.S. Food and Drug Administration (FDA) (Accessed: 4/16/2013
****Advanced Pain & Neuromuscular Consultants have NEVER USED PRODUCTS FROM THIS COMPANY.
307 E. New Haven Avenue, Melbourne, FL 32901
307 E. New Haven Avenue
Melbourne, FL 32901
8075 Spyglass Hill Road, Viera, FL 32940
8075 Spyglass Hill Road,
Viera, FL 32940
FDA Opioid Rulings Slammed(MedPage Today) -- FDA decisions about prescription opioid painkillers have been inconsistent, and the agency should make future decisions with greater transparency, according to drug safety researchers. Read More
Morning Break: Prisons and Obamacare, Pharma Scouts(MedPage Today) -- Health news and commentary from around the Web, gathered by the MedPage Today staff. Read More
Teens Likely to Get Opioid Rx for Headaches(MedPage Today) -- Nearly half of teens who visit a doctor complaining of headache pain walk away with a prescription for a narcotic painkiller, researchers found. Read More
Late Chemo at Odds With Patient Wishes? (CME/CE)(MedPage Today) -- Chemotherapy in the last months of life significantly increased cancer patients' odds of intensive treatment in the last week of life, late referral to hospice care, and death away from their preferred place, investigators reported. Read More
Medtronic Sued by 1,000 Infuse Patients(MedPage Today) -- Medtronic said about 1,000 people have sued the company over its bone morphogenetic protein-2 product, Infuse, and that many more lawsuits may be coming. Read More
Pregnant Women On Opioids: The Pain Medicine News Report(MedPage Today) -- A regular update on what's new in surgery from our friends at Pain Medicine News. Read More
Schumer to HHS: Ditch Zohydro(MedPage Today) -- During a Monday press briefing, Sen. Charles Schumer (D-N.Y.) called on Health and Human Services Secretary Kathleen Sebelius to overturn the FDA's approval of Zohydro, a potent hydrocodone-only opioid approved last October. Read More
Morning Break: Doc Pay Gap Shrinks, Burnout Cure(MedPage Today) -- Health news and commentary from around the Web, gathered by the MedPage Today staff. Read More
Marijuana: Do Risks Outweigh Benefits in RA? (CME/CE)(MedPage Today) -- Rheumatologists should not currently be recommending the use of medical marijuana to their patients for relief of chronic pain, researchers stated. Read More
Striking a Nerve: Studies to Watch at AAN(MedPage Today) -- A look at noteworthy abstracts slated for presentation at the American Academy of Neurology's annual meeting at the end of April. Read More
This Week in Medical News: Benzos, STDs, and IVF(MedPage Today) -- Although much has been written about the "opioid epidemic," less attention has been focused on the relatively common practice of prescribing benzodiazapines in combination with opioids, a practice that may increase the risk of fatal overdoses, reported John Fauber, Kristina Fiore, and Elbert Chu in "Killing Pain: Benzo 'Boost' Can Be Deadly," a three-part investigative series from the Milwaukee Journal Sentinel and MedPage Today. Read More
Killing Pain: Script by Script(MedPage Today) -- Thirty million prescriptions for narcotic painkillers were written nationwide in 2013 by non-doctors, according to data obtained by MedPage Today and the Milwaukee Journal Sentinel, but primary care physicians top the benzodiazepine script parade. Read More
Senators Investigate Alleged Zohydro Pay-to-Play(MedPage Today) -- Two senators say they want answers about a long-running series of private meetings between drug company executives and federal regulators, events that were held at expensive hotels and were paid for by the drug firms. Read More
Killing Pain: Fewer Opioid Scripts(MedPage Today) -- Doctors and other health providers wrote about 11 million fewer prescriptions for narcotic painkillers in 2013 than in 2012, but some experts expected a bigger drop-off given the national focus on opioid abuse. Read More
Zohydro: Is This Painkiller FDA's Fatal Mistake?(MedPage Today) -- A coalition of several advocacy groups wants to reinforce a message sent to FDA by other key policymakers: rescind approval of the powerful painkiller Zohydro. Read More